Sima et al., 2019 - Google Patents
The effect of an antimicrobial mixture on cryptosporidiumSima et al., 2019
View PDF- Document ID
- 10148651114822795848
- Author
- Sima F
- Stratakos A
- Ward P
- Gundogdu O
- Stef L
- Ioan P
- Elena P
- Pacala N
- Lazar V
- Corcionivoschi N
- Publication year
- Publication venue
- AgroLife Scientific Journal
External Links
Snippet
Cryptosporidium is an enteric protozoan parasite that causes gastrointestinal disorders in humans and in a wide range of animals, mainly in calves. As there is no available efficient treatment for cryptosporidiosis, in this study we evaluated the effect of Auranta 3001, a …
- 230000000694 effects 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abd El-Hack et al. | Approaches to prevent and control Campylobacter spp. colonization in broiler chickens: a review | |
| Daugschies et al. | Eimeriosis in cattle: current understanding | |
| RU2741836C2 (en) | Probiotic and prebiotic compositions | |
| WO2007058027A1 (en) | Harmful bacterium control agent containing bacillus thuringiensis | |
| Fairbrother et al. | Escherichia coli infections | |
| Zhang et al. | Dietary genistein supplementation improves intestinal mucosal barrier function in Escherichia coli O78-challenged broilers | |
| HUT67007A (en) | Preparations containing biologically activ agent wich are absorbed in the superior intestinal tract of animals | |
| CA2893990C (en) | Probiotic strains for the treatment and/or prevention of diarrhea | |
| JPH0838064A (en) | Feed capable of preventing infection of harmful bacterium | |
| US20180028490A1 (en) | Methods Of Treating Diarrhea And Promoting Intestinal Health In Non-Human Animals | |
| US20210275603A1 (en) | Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders | |
| Kassaify et al. | Effect of food protein supplements on Salmonella Enteritidis infection and prevention in laying hens | |
| Lorenzoni | Poultry diseases influenced by gastrointestinal health: traditional treatments and innovative solutions | |
| Sima et al. | The effect of an antimicrobial mixture on cryptosporidium | |
| BT et al. | Effect of dietary chitosan nanoparticles on immune response and disease resistance against Aeromonas hydrophila infection in tropical herbivore fish (rohu, Labeo rohita) | |
| JP5240811B2 (en) | Japanese red sea bream sliding bacteriosis vaccine, Japanese red sea bream sliding bacteriosis vaccine composition and method for preventing red sea bream sliding bacteriosis | |
| US20180099011A1 (en) | Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders | |
| JP7510360B2 (en) | Method for preparing a composition comprising killed or inactivated Methanobrevibacter Archaebacteria cells and the resulting composition | |
| WO2004052379A1 (en) | Antidiarrheal composition | |
| Luoga et al. | The anthelmintic efficacy of papaya latex in a rodent–nematode model is not dependent on fasting before treatment | |
| Koutoulis et al. | Pharmacokinetics and clinical assessment of amoxicillin for the control of necrotic enteritis in broiler-breeders under field conditions | |
| WO2018071532A1 (en) | Compositions and methods for treating chronic fatigue syndrome and related disorders | |
| Di Pietro | Development of a protocol with concentrated bacteria for fecal microbiota transplantation and impact on the equine fecal microbiota after antibiotic-induced dysbiosis | |
| JP2023510694A (en) | Association of FAECALIBACTERIUM PRAUSNITZII strain CNCM I-4573 with PENTASA® for the treatment and prevention of gastroenteritis | |
| Chauhan et al. | Immunopathology of Diarrhea in Animals |